{"id":138743,"date":"2018-04-09T10:14:38","date_gmt":"2018-04-09T10:14:38","guid":{"rendered":"https:\/\/stg.strategist1trial.com\/de-studie-strategist3\/"},"modified":"2025-09-15T16:37:35","modified_gmt":"2025-09-15T16:37:35","slug":"de-studie-strategist3","status":"publish","type":"page","link":"https:\/\/stg.strategist3trial.com\/nl-be\/","title":{"rendered":"De studie StrateGIST3"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;821871&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;iphone&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;bottom&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; expand_height=&#8221;yes&#8221; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;177675&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;5&#8243;][vc_single_image media=&#8221;138415&#8243; media_width_percent=&#8221;36&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;624267&#8243;][vc_column_text text_color=&#8221;color-jevc&#8221; uncode_shortcode_id=&#8221;137548&#8243; text_color_type=&#8221;uncode-palette&#8221;]IDRX-42 (GSK6042981) is een zeer selectieve en krachtige remmer van het KIT-eiwit. Dit eiwit is overactief bij veel mensen met GIST, wat leidt tot groei en ophoping van kankercellen.[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112267&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;fixed&#8221; back_position=&#8221;center top&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;159258&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138415&#8243; media_width_percent=&#8221;45&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;927066&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;321186&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Meer informatie[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van de studie, wie mee kunnen doen, de studiegeneesmiddelen en wat u kunt verwachten tijdens de studie.[\/vc_column_text][vc_single_image media=&#8221;123014&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112266&#8243; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center bottom&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_color=&#8221;color-681992&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; row_name=&#8221;iphone&#8221; el_class=&#8221;gradient&#8221; uncode_shortcode_id=&#8221;204395&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_bottom_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; style=&#8221;dark&#8221; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;7&#8243; align_mobile=&#8221;align_center_mobile&#8221; mobile_width=&#8221;0&#8243; css_animation=&#8221;bottom-t-top&#8221; animation_delay=&#8221;200&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;276875&#8243; column_width_pixel=&#8221;1000&#8243;][vc_empty_space empty_h=&#8221;1&#8243;][vc_single_image media=&#8221;138415&#8243; media_width_percent=&#8221;60&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;482822&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;155178&#8243; width=&#8221;216&#8243; link=&#8221;url:%23study-description|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Meer informatie[\/vc_button][vc_empty_space empty_h=&#8221;0&#8243;][vc_column_text text_color=&#8221;color-196438&#8243; uncode_shortcode_id=&#8221;111155&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van de studie, wie mee kunnen doen, de studiegeneesmiddelen en wat u kunt verwachten tijdens de studie.[\/vc_column_text][vc_empty_space empty_h=&#8221;0&#8243;][vc_single_image media=&#8221;123014&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;157773&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;50&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-681992&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; bottom_divider=&#8221;tilt&#8221; uncode_shortcode_id=&#8221;168548&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;study-description&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; column_width_pixel=&#8221;1000&#8243; uncode_shortcode_id=&#8221;145453&#8243;][vc_custom_heading text_color=&#8221;color-138503&#8243; heading_semantic=&#8221;h1&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;671518&#8243; text_color_type=&#8221;uncode-palette&#8221;]<strong>Wat is StrateGIST 3?<\/strong>[\/vc_custom_heading][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;775611&#8243; text_color_type=&#8221;uncode-palette&#8221;]<span style=\"font-weight: 400\"><strong style=\"font-size: 20px;color: #ffffff\">StrateGIST 3<\/strong> is een klinische studie waarin een experimenteel medicijn (studiegeneesmiddel) met de naam IDRX-42 (GSK6042981) wordt getest bij volwassenen met uitgezaaide en\/of niet-opereerbare gastro-intestinale stromale tumoren (GIST) die erger zijn geworden tijdens eerstelijnsbehandeling met imatinib of deze niet verdroegen.<\/span> <span style=\"font-weight: 400\">Onderzoekers willen meer te weten komen over de veiligheid van IDRX-42 (GSK6042981) en de effecten van het middel vergelijken met sunitinib, een behandeling die in sommige landen is goedgekeurd voor het type GIST dat wordt onderzocht.<\/span> <span style=\"font-weight: 400\">Deze studie bouwt voort op bevindingen over IDRX-42 (GSK6042981) uit een\u00a0eerdere studie met pati\u00ebnten met GIST.<\/span>[\/vc_column_text][vc_column_text text_color=&#8221;color-xsdn&#8221; uncode_shortcode_id=&#8221;246950&#8243; text_color_type=&#8221;uncode-palette&#8221;]Klik hier om een video over StrateGIST 3 te bekijken. De video gaat onder andere over het doel van de studie, wie mee kunnen doen, de studiegeneesmiddelen en wat u kunt verwachten tijdens de studie.[\/vc_column_text][vc_empty_space empty_h=&#8221;3&#8243;][vc_button button_color=&#8221;color-196438&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; display=&#8221;inline&#8221; link=&#8221;url:%23location|title:Join%20the%20Study|&#8221; button_color_type=&#8221;uncode-palette&#8221; width=&#8221;216&#8243; uncode_shortcode_id=&#8221;132884&#8243;]Zoek een studiecentrum[\/vc_button][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;7&#8243; bottom_padding=&#8221;7&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;152579&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;179542&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;242247&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>Wat gebeurt er tijdens de studie?<\/strong>[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_column_text uncode_shortcode_id=&#8221;183718&#8243;]<span style=\"font-weight: 400\">In de studie wordt het studiegeneesmiddel IDRX-42 getest bij volwassenen met uitgezaaide en\/of niet-opereerbare gastro-intestinale stromale tumoren (GIST) die erger zijn geworden tijdens eerstelijnsbehandeling met imatinib of die deze niet verdroegen. Het doel is de effecten van IDRX-42 te vergelijken met sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 is een studiegeneesmiddel en is door geen enkele gezondheidsautoriteit goedgekeurd voor gebruik buiten een klinische studie.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;4&#8243;][\/vc_column][vc_column column_width_percent=&#8221;95&#8243; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; css_animation=&#8221;alpha-anim&#8221; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;900895&#8243;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;954054&#8243;]Ge\u00efnformeerde toestemming[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;195636&#8243;]<span style=\"font-weight: 400\">V\u00f3\u00f3r u beslist of u wilt deelnemen, neemt het onderzoeksteam de details van de studie met u door. Dit gaat onder andere over mogelijke risico&#8217;s en voordelen en wat u kunt verwachten als u meedoet. Als u besluit om mee te doen, wordt u gevraagd om een formulier voor ge\u00efnformeerde toestemming te ondertekenen. Dit bevestigt dat u de studie begrijpt en bereid bent deel te nemen om te bepalen of u geschikt bent.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;178847&#8243;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;350149&#8243;]<span style=\"font-weight: 400\">Om te kijken of u in aanmerking komt, hebt u minstens \u00e9\u00e9n afspraak in het studiecentrum om vragen over uw gezondheid en medicatie te beantwoorden en om een aantal tests te ondergaan.<\/span>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;169390&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;209503&#8243;]Studiebehandeling[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;132873&#8243;]<span style=\"font-weight: 400\">Als u in aanmerking komt voor deelname aan de studie, wordt u willekeurig in een groep ingedeeld waarin u ofwel IDRX-42 of sunitinib (de goedgekeurde behandeling) krijgt.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 wordt verstrekt als tabletten die eenmaal per dag thuis worden ingenomen. IDRX-42 wordt elke dag ingenomen. Sunitinib wordt 28 dagen achtereen ingenomen, gevolgd door een pauze van 14 dagen (tenzij u andere instructies krijgt van uw arts).\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400\">Tijdens de periode met de studiebehandeling komt u naar het studiecentrum voor gezondheidscontroles en om te zien hoe uw kanker reageert op de studiebehandeling (IDRX-42 of sunitinib).<\/span><\/p>\n<p><span style=\"font-weight: 400\">Als u sunitinib krijgt en uw kanker verergert, kunt u mogelijk overschakelen naar IDRX-42.<\/span><\/p>\n<p><strong>De studiebehandeling (IDRX-42 of sunitinib), afspraken en studiegerelateerde tests zullen worden betaald door de opdrachtgever van de klinische studie. Er is een vergoeding beschikbaar voor reiskosten om naar afspraken te komen.<\/strong>[\/vc_column_text][vc_separator sep_color=&#8221;color-prif&#8221; uncode_shortcode_id=&#8221;447472&#8243; sep_color_type=&#8221;uncode-palette&#8221;][vc_custom_heading text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;165143&#8243;]Opvolging[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;435261&#8243;]<span style=\"font-weight: 400\">Als u en uw arts besluiten te stoppen met de studiebehandeling, heeft u nog twee afspraken en elke drie maanden een telefonisch gesprek met het studieteam.<\/span>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-681992&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;626023&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fnl-be%2Fveelgestelde-vragen%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Bekijk de veelgestelde vragen over StrateGIST 3[\/vc_button][vc_empty_space empty_h=&#8221;2&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; back_color=&#8221;color-138503&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_color=&#8221;color-681992&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;150&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;944839&#8243; back_color_type=&#8221;uncode-palette&#8221; shape_top_color_type=&#8221;uncode-palette&#8221;][vc_column column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; sticky=&#8221;yes&#8221; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;580905&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; position_horizontal=&#8221;right&#8221; position_vertical=&#8221;middle&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;111259&#8243;][vc_empty_space empty_h=&#8221;3&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;506177&#8243;]<strong>Wat gebeurt er tijdens de studie?<\/strong>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;105390&#8243;]<span style=\"font-weight: 400\">In de studie wordt het studiegeneesmiddel IDRX-42 (GSK6042981) getest bij volwassenen met uitgezaaide en\/of niet-opereerbare gastro-intestinale stromale tumoren (GIST) bij wie de ziekte erger is geworden tijdens de behandeling met imatinib of die de bijwerkingen van imatinib niet verdragen. Het doel is de veiligheid en effecten van IDRX-42 (GSK6042981) te vergelijken met sunitinib.<\/span><\/p>\n<p><span style=\"font-weight: 400\">IDRX-42 (GSK6042981) is een studiegeneesmiddel en is door geen enkele gezondheidsautoriteit goedgekeurd voor gebruik buiten een klinische studie.<\/span>[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;158094&#8243;][vc_custom_heading uncode_shortcode_id=&#8221;175823&#8243;]Uw traject in StrateGIST 3[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;663441&#8243;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;694467&#8243;][vc_single_image media=&#8221;138952&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;844616&#8243;][vc_single_image media=&#8221;138929&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;765789&#8243;][vc_single_image media=&#8221;138906&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;150290&#8243;][vc_single_image media=&#8221;138883&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;193354&#8243;][\/vc_column_inner][\/vc_row_inner][vc_row_inner row_inner_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; limit_content=&#8221;&#8221; uncode_shortcode_id=&#8221;143909&#8243;][vc_column_inner width=&#8221;1\/1&#8243;][vc_single_image media=&#8221;138535&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;165287&#8243;][vc_single_image media=&#8221;138475&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;197707&#8243;][vc_single_image media=&#8221;138515&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;840834&#8243;][vc_single_image media=&#8221;138475&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;746250&#8243;][vc_single_image media=&#8221;112312&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;108810&#8243;][vc_single_image media=&#8221;138475&#8243; media_width_percent=&#8221;11&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;121070&#8243;][vc_single_image media=&#8221;138495&#8243; media_width_percent=&#8221;85&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;868346&#8243;][\/vc_column_inner][\/vc_row_inner][vc_empty_space empty_h=&#8221;3&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;888870&#8243;][vc_button border_width=&#8221;0&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategist1trial.com%2Fnl-be%2Fveelgestelde-vragen%2F|title:FAQs|&#8221; uncode_shortcode_id=&#8221;185672&#8243;]FAQs[\/vc_button][vc_empty_space empty_h=&#8221;3&#8243;][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; back_image=&#8221;111788&#8243; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_top_divider=&#8221;default&#8221; top_divider=&#8221;tilt&#8221; shape_top_h_use_pixel=&#8221;&#8221; shape_top_height=&#8221;100&#8243; shape_top_opacity=&#8221;100&#8243; shape_top_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider=&#8221;tilt&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; shape_bottom_opacity=&#8221;100&#8243; shape_bottom_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;155709&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;locations&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_empty_space][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;176181&#8243;]<span style=\"font-weight: 400\">Wilt u meer weten? <\/span>[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;183639&#8243;]<span style=\"font-weight: 400\">Vraag uw arts om meer informatie en klik op de link hieronder om een StrateGIST 1-studiecentrum bij u in de buurt te vinden.<\/span>[\/vc_column_text][vc_column_text uncode_shortcode_id=&#8221;654154&#8243;]<b>Deelname aan de studie is vrijwillig en u kunt op elk moment met de studie stoppen.<\/b>[\/vc_column_text][vc_empty_space empty_h=&#8221;2&#8243;][vc_button button_color=&#8221;color-773321&#8243; border_animation=&#8221;btn-ripple-out&#8221; border_width=&#8221;0&#8243; uncode_shortcode_id=&#8221;214268&#8243; link=&#8221;url:https%3A%2F%2Fstg.strategisttrials.com%2Ffaqs%2F|title:FAQs|&#8221; button_color_type=&#8221;uncode-palette&#8221;]Zoek een studiecentrum[\/vc_button][vc_empty_space empty_h=&#8221;5&#8243;][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;936538&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;location&#8221;][vc_column column_width_use_pixel=&#8221;yes&#8221; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/1&#8243; uncode_shortcode_id=&#8221;881793&#8243; column_width_pixel=&#8221;900&#8243;][vc_custom_heading text_size=&#8221;&#8221; uncode_shortcode_id=&#8221;118699&#8243;]Wilt u meer weten?[\/vc_custom_heading][vc_column_text uncode_shortcode_id=&#8221;125329&#8243;]<span style=\"font-weight: 400\">Vraag uw arts om meer informatie over StrateGIST 3.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Klik op een locatie op de kaart hieronder om een StrateGIST 3-studiecentrum bij u in de buurt te vinden. StrateGIST 3 zal beschikbaar zijn in maximaal 150 locaties voor klinische studies wereldwijd. Houd de locaties in de gaten, er kunnen nieuwe locaties beschikbaar worden.<\/span><\/p>\n<p><span style=\"font-weight: 400\">Reiskosten om naar studieafspraken te komen worden vergoed.<\/span>[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;2&#8243; top_padding=&#8221;2&#8243; bottom_padding=&#8221;5&#8243; back_color=&#8221;color-xsdn&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;150898&#8243; back_color_type=&#8221;uncode-palette&#8221;][vc_column width=&#8221;1\/1&#8243;][vc_column_text uncode_shortcode_id=&#8221;326645&#8243;]                <script>\r\n                    const mapStyle = [];\r\n                    const marker_icon = '';\r\n                <\/script>\r\n\t\t\t            <div class=\"store-info-container \">\r\n                <div class=\"store-locations\">\r\n                    <div class=\"store-locations-search OneLinkTx\">\r\n                        <form role=\"search\" class=\"store-search-form\">\r\n                            <label for=\"search-text\"><\/label>\r\n                            <input type=\"text\" value name=\"search-text\" id=\"search-text\"\r\n                                   placeholder=\"Enter a location\">\r\n                            <input type=\"image\" id=\"search-btn\" alt=\"Search\" src=\"https:\/\/stg.strategist3trial.com\/wp-content\/plugins\/jh-wp-site-listing-main\/images\/icon-arrow-right.svg\">\r\n                            <input type=\"hidden\" id=\"place_lat\" value=\"\">\r\n                            <input type=\"hidden\" id=\"place_lng\" value=\"\">\r\n                            <input type=\"hidden\" id=\"show_map\" name=\"show_map\"\r\n                                   value=\"yes\">\r\n\t\t\t\t\t\t\t                            <input type=\"hidden\" id=\"language_code\" value=\"nl-be\">\r\n                        <\/form>\r\n\t\t\t\t\t\t                            <div class=\"my-location\">\r\n                                <a href=\"javascript:void(0);\" onClick=\"getuser_location();\">\r\n\t\t\t\t\t\t\t\t\tUse my Location                                <\/a>\r\n                            <\/div>\r\n\t\t\t\t\t\t                    <\/div>\r\n                    <h5 class=\"store-locations-result-info OneLinkTx\">\r\n\t\t\t\t\t\tShowing                        <span id=\"found-results\"> 0<\/span> Results Near You                    <\/h5>\r\n\t\t\t\t\t                    <div class=\"store-locations-list\" id=\"ajax_results_wrapper\">\r\n                    <\/div>\r\n                <\/div>\r\n\t\t\t\t                    <div class=\"store-map-wrapper\">\r\n                        <div id=\"store-map\">\r\n                        <\/div>\r\n                    <\/div>\r\n\t\t\t\t            <\/div>\r\n\t\t\t[\/vc_column_text][\/vc_column][\/vc_row][vc_row row_height_percent=&#8221;0&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;3&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; desktop_visibility=&#8221;yes&#8221; medium_visibility=&#8221;yes&#8221; mobile_visibility=&#8221;yes&#8221; uncode_shortcode_id=&#8221;107948&#8243;][vc_column width=&#8221;1\/1&#8243;][vc_row_inner limit_content=&#8221;&#8221;][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;136670&#8243;][vc_raw_html]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[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;961362&#8243; subheading=&#8221;(meer informatie over de studie en instemmen met deelname)&#8221;]Ge\u00efnformeerde toestemming[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;443498&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL2hlYWx0aC1zdGF0dXMucG5nIi8+IiBjb250ZW50ID0gIjxoMz5TY3JlZW5pbmc8L2gzPjxkaXY+PGg2Pk9tIHRlIGtpamtlbiBvZiB1IGluIGFhbm1lcmtpbmcga29tdCwgaGVlZnQgdSBtaW5zdGVucyDDqcOpbiBhZnNwcmFhayBpbiBoZXQgc3R1ZGllY2VudHJ1bSBvbSB2cmFnZW4gb3ZlciB1dyBnZXpvbmRoZWlkIGVuIG1lZGljYXRpZSB0ZSBiZWFudHdvb3JkZW4gZW4gb20gZWVuIGFhbnRhbCB0ZXN0cyB0ZSBvbmRlcmdhYW4uPC9oNj48YnI+PGJyPjwvZGl2PiJd[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;927570&#8243; subheading=&#8221;(kijken of u in aanmerking komt)&#8221;]<span class='tooltipsall tooltip_post_id_112286 classtoolTips112286'>Screening<\/span>[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;755785&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL1RyZWF0bWVudC5wbmciLz4iIGNvbnRlbnQgPSAiPGgzPlN0dWRpZWJlaGFuZGVsaW5nPC9oMz48ZGl2PjxoNj5BbHMgdSBpbiBhYW5tZXJraW5nIGtvbXQgdm9vciBkZWVsbmFtZSBhYW4gZGUgc3R1ZGllLCB3b3JkdCB1IHdpbGxla2V1cmlnIGluIGVlbiBncm9lcCBpbmdlZGVlbGQgd2FhcmluIHUgb2Z3ZWwgSURSWC00MiBvZiBzdW5pdGluaWIgKGRlIGdvZWRnZWtldXJkZSBiZWhhbmRlbGluZykga3Jpamd0LiAKPGJyPgpJRFJYLTQyIHdvcmR0IHZlcnN0cmVrdCBhbHMgdGFibGV0dGVuIGRpZSBlZW5tYWFsIHBlciBkYWcgdGh1aXMgd29yZGVuIGluZ2Vub21lbi4gSURSWC00MiB3b3JkdCBlbGtlIGRhZyBpbmdlbm9tZW4uIFN1bml0aW5pYiB3b3JkdCAyOCBkYWdlbiBhY2h0ZXJlZW4gaW5nZW5vbWVuLCBnZXZvbGdkIGRvb3IgZWVuIHBhdXplIHZhbiAxNCBkYWdlbiAodGVuemlqIHUgYW5kZXJlIGluc3RydWN0aWVzIGhlZWZ0IHZhbiB1dyBhcnRzKS4gCjxicj4KVGlqZGVucyBkZSBiZWhhbmRlbGluZ3NwZXJpb2RlIGtvbXQgdSBuYWFyIGhldCBzdHVkaWVjZW50cnVtIHZvb3IgZ2V6b25kaGVpZHNjb250cm9sZXMgZW4gb20gdGUgemllbiBob2UgdXcga2Fua2VyIHJlYWdlZXJ0IG9wIGRlIHN0dWRpZWJlaGFuZGVsaW5nIChJRFJYLTQyIG9mIHN1bml0aW5pYikuCjxicj4KQWxzIHUgc3VuaXRpbmliIG5lZW10IGVuIHV3IGthbmtlciB2ZXJlcmdlcnQsIGt1bnQgdSBtb2dlbGlqayBvdmVyc2NoYWtlbGVuIG5hYXIgSURSWC00Mi4KPGJyPgpEZSBzdHVkaWViZWhhbmRlbGluZyAoSURSWC00MiBvZiBzdW5pdGluaWIpLCBhZnNwcmFrZW4gZW4gc3R1ZGllZ2VyZWxhdGVlcmRlIHRlc3RzIHp1bGxlbiB3b3JkZW4gYmV0YWFsZCBkb29yIGRlIG9wZHJhY2h0Z2V2ZXIgdmFuIGRlIGtsaW5pc2NoZSBzdHVkaWUuIEVyIGlzIGVlbiB2ZXJnb2VkaW5nIGJlc2NoaWtiYWFyIHZvb3IgcmVpc2tvc3RlbiBvbSBuYWFyIGFmc3ByYWtlbiB0ZSBrb21lbi48L2g2Pjxicj48YnI+PC9kaXY+Il0=[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;665102&#8243; subheading=&#8221;IDRX-42 of sunitinib&#8221;]Studiebehandeling[\/vc_custom_heading][\/vc_column_inner][vc_column_inner column_width_percent=&#8221;100&#8243; align_horizontal=&#8221;align_center&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/4&#8243; uncode_shortcode_id=&#8221;127480&#8243;][vc_raw_html]W3Rvb2x0aXBzIGtleXdvcmQgPSAiPGltZyBzcmM9Imh0dHBzOi8vc3RnLnN0cmF0ZWdpc3QxdHJpYWwuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDI0LzExL0FnZS5wbmciLz4iIGNvbnRlbnQgPSAiPGgyPk9wdm9sZ2luZzwvaDI+PGRpdj48aDY+QWxzIHUgZW4gdXcgYXJ0cyBiZXNsdWl0ZW4gdGUgc3RvcHBlbiBtZXQgZGUgc3R1ZGllYmVoYW5kZWxpbmcsIGhlZWZ0IHUgbm9nIHR3ZWUgYWZzcHJha2VuIGVuIGVsa2UgZHJpZSBtYWFuZGVuIGVlbiB0ZWxlZm9uaXNjaCBnZXNwcmVrIG1ldCBoZXQgc3R1ZGlldGVhbS48L2g2Pjxicj48YnI+PC9kaXY+Il0=[\/vc_raw_html][vc_custom_heading heading_semantic=&#8221;h3&#8243; text_size=&#8221;h3&#8243; uncode_shortcode_id=&#8221;152286&#8243;]Opvolging[\/vc_custom_heading][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row row_height_percent=&#8221;100&#8243; back_color=&#8221;color-138503&#8243; back_image=&#8221;112255&#8243; back_repeat=&#8221;no-repeat&#8221; back_attachment=&#8221;scroll&#8221; back_position=&#8221;center center&#8221; parallax=&#8221;yes&#8221; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; enable_bottom_divider=&#8221;default&#8221; bottom_divider_inv=&#8221;tilt&#8221; shape_bottom_invert=&#8221;yes&#8221; shape_bottom_flip=&#8221;yes&#8221; shape_bottom_h_use_pixel=&#8221;&#8221; shape_bottom_height=&#8221;100&#8243; [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-138743","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/pages\/138743","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/comments?post=138743"}],"version-history":[{"count":0,"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/pages\/138743\/revisions"}],"wp:attachment":[{"href":"https:\/\/stg.strategist3trial.com\/nl-be\/wp-json\/wp\/v2\/media?parent=138743"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}